Persistent Methicillin-Resistant Bacteremia: Host, Pathogen, and Treatment.

Antibiotics (Basel)

Department of Medicine, Division of Infectious Disease, Duke University Medical Center, Durham, NC 27710, USA.

Published: February 2023

Methicillin-resistant (MRSA) is a devastating pathogen responsible for a variety of life-threatening infections. A distinctive characteristic of this pathogen is its ability to persist in the bloodstream for several days despite seemingly appropriate antibiotics. Persistent MRSA bacteremia is common and is associated with poor clinical outcomes. The etiology of persistent MRSA bacteremia is a result of the complex interplay between the host, the pathogen, and the antibiotic used to treat the infection. In this review, we explore the factors related to each component of the host-pathogen interaction and discuss the clinical relevance of each element. Next, we discuss the treatment options and diagnostic approaches for the management of persistent MRSA bacteremia.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044482PMC
http://dx.doi.org/10.3390/antibiotics12030455DOI Listing

Publication Analysis

Top Keywords

persistent mrsa
12
mrsa bacteremia
12
host pathogen
8
persistent
4
persistent methicillin-resistant
4
bacteremia
4
methicillin-resistant bacteremia
4
bacteremia host
4
pathogen
4
pathogen treatment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!